Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalom D Goldberg

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Pharmaceutics|October 23, 2021
A Strategy for Selective Deletion of Autoimmunity-Related T Cells by pMHC-Targeted DeliveryShalom D Goldberg, Nathan Felix, Michael McCauley, et al.
Molecular Cancer Therapeutics|February 7, 2024
Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and TolerabilityShalom D Goldberg, Tero Satomaa, Olulanu Aina, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Pharmaceutics|October 23, 2021
A Strategy for Selective Deletion of Autoimmunity-Related T Cells by pMHC-Targeted DeliveryShalom D Goldberg, Nathan Felix, Michael McCauley, et al.
Molecular Cancer Therapeutics|February 7, 2024
Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and TolerabilityShalom D Goldberg, Tero Satomaa, Olulanu Aina, et al.
Pageof 2